Experimental and calculated shift in pK(a) upon binding of phosphotyrosine peptide to the SH2 domain of p56(lck).

The pH dependence of the affinity of a 11-mer phosphotyrosine (pY) peptide (EPQpYEEIPIYL-NH2) for the SH2 domain of the tyrosine kinase p56(lck) was investigated with surface plasmon resonance (SPR). From SPR competition experiments the affinity in solution was obtained. The pH dependence of the affinity in solution can be well described by a proton linkage model with a single pK(a) shift upon binding, from 6.1 to 4.7. This shift is ascribed to the transition from the -2 to the -1 ionisation state of the tyrosine phosphate group. Based on the X-ray structure for the complex with Lck SH2, a pK(a) value of 5.3 for the bound pY peptide was computed, modelling the solvated protein as a system of point charges in a continuum. With the phosphate in the -2 state the binding energy is 1.8 kcal/mol more favourable than for the -1 state, corresponding to a 20-fold higher affinity. A proper charge is relevant in the design of potential therapeutic Lck SH2 ligands with mimics for the metabolically unstable tyrosine phosphate group.

[1]  S. Shoelson,et al.  Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. , 1994, Biochemistry.

[2]  P. Furet,et al.  Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1. , 2000, Bioorganic & medicinal chemistry letters.

[3]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[4]  M. Fischer,et al.  Kinetic analysis of the mass transport limited interaction between the tyrosine kinase lck SH2 domain and a phosphorylated peptide studied by a new cuvette-based surface plasmon resonance instrument. , 2000, Analytical biochemistry.

[5]  W. L. Jorgensen,et al.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.

[6]  J. Forman-Kay,et al.  pH Titration studies of an SH2 domain‐phosphopeptide complex: Unusual histidine and phosphate pKa values , 1997, Protein science : a publication of the Protein Society.

[7]  T K Sawyer,et al.  Src homology‐2 domains: Structure, mechanisms, and drug discovery , 1998, Biopolymers.

[8]  G L Gilliland,et al.  The three-dimensional structure of a glutathione S-transferase from the mu gene class. Structural analysis of the binary complex of isoenzyme 3-3 and glutathione at 2.2-A resolution. , 1992, Biochemistry.

[9]  R. Panek,et al.  Progress in the development of inhibitors of SH2 domains. , 2000, Current pharmaceutical design.

[10]  J. Proudfoot,et al.  Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements. , 1999, Journal of medicinal chemistry.

[11]  Tony Pawson,et al.  Protein modules and signalling networks , 1995, Nature.

[12]  S. Shoelson,et al.  SH2 and PTB domain interactions in tyrosine kinase signal transduction. , 1997, Current opinion in chemical biology.

[13]  J. M. Bradshaw,et al.  Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide. , 1998, Biochemistry.

[14]  J. Proudfoot,et al.  Carboxymethyl-phenylalanine as a Replacement for Phosphotyrosine in SH2 Domain Binding* , 1998, The Journal of Biological Chemistry.

[15]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[16]  Joanna Trylska,et al.  Thermodynamic linkage between the binding of protons and inhibitors to HIV‐1 protease , 2008, Protein science : a publication of the Protein Society.

[17]  M. Gilson,et al.  Prediction of pH-dependent properties of proteins. , 1994, Journal of molecular biology.

[18]  M. Botfield,et al.  Chapter 24. SH2 and SH3 Domains: Choreographers of Multiple Signaling Pathways , 1995 .

[19]  S. Jakes,et al.  Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides. , 1995, Journal of medicinal chemistry.